Real-World Comparative Evaluation of Add-On Glucagon-like Peptide 1 Receptor Agonist in Type 2 Diabetes Treated with or without Insulin

• Main Authors: Hsuan-Wen Chou (Author), Kai-Pi Cheng (Author), An-Chi Lin (Author), Hao-Chang Hung (Author), Ching-Han Lin (Author), Chih-Chen Wang (Author), Hung-Tsung Wu (Author), Horng-Yih Ou (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Glucagon-like peptide 1 receptor agonist (GLP-1 RA) is a potent antidiabetic agent with cardiorenal and weight-losing benefits in patients with type 2 diabetes (T2D). The combination of GLP-1 RA with basal insulin has been suggested in several clinical studies as a useful treatment for intensifying...